Company · Ottawa, Ontario, Canada
Marcan Pharmaceuticals Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 464
- 381 authorized now
- Natural health products
- 3
- 3 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 510
Drug products
Authorized products first.
Showing 300 of 464 drug products. For the rest, search Health Canada’s database.
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| MAR-K8 | 80148473 | Active | |
| MAR-K20 | 80148474 | Active | |
| Sennosides | 80010509 | Active |
Notices of Compliance
Newest first.
- MAR-FLECAINIDESeptember 25, 2026 · NOC 38366 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TREPROSTINIL INJECTIONSeptember 11, 2026 · NOC 38276 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-RAMIPRILSeptember 3, 2026 · NOC 38229 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-CITALOPRAMAugust 27, 2026 · NOC 37842 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-CITALOPRAMAugust 27, 2026 · NOC 38179 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CARBOPLATIN INJECTION BPAugust 20, 2026 · NOC 38152 · Abbreviated New Drug Submission (ANDS)
- PROPOFOL INJECTIONAugust 19, 2026 · NOC 38143 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR- MYCOPHENOLATE MOFETILJuly 24, 2026 · NOC 37987 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-LEFLUNOMIDEJuly 6, 2026 · NOC 37845 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-ZOPICLONEJuly 6, 2026 · NOC 37919 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-TEMOZOLOMIDEJune 23, 2026 · NOC 37758 · Abbreviated New Drug Submission (ANDS)
- MAR-DULOXETINEJune 12, 2026 · NOC 37702 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-RAMIPRILJune 10, 2026 · NOC 37692 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-PAROXETINEJune 8, 2026 · NOC 37675 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-DILTIAZEM CDMay 14, 2026 · NOC 37542 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-ZOPICLONEApril 20, 2026 · NOC 37346 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-MONTELUKASTApril 17, 2026 · NOC 37341 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-CELECOXIBApril 13, 2026 · NOC 37318 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PROPOFOL INJECTIONMarch 13, 2026 · NOC 37092 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-TOPIRAMATEMarch 13, 2026 · NOC 37099 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-EZETIMIBEMarch 4, 2026 · NOC 37034 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BLEOMYCIN FOR INJECTIONMarch 3, 2026 · NOC 37036 · Abbreviated New Drug Submission (ANDS)
- MAR-DILTIAZEM CDFebruary 25, 2026 · NOC 36996 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-ATORVASTATINJanuary 30, 2026 · NOC 36910 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ERIBULIN MESYLATE INJECTIONJanuary 9, 2026 · NOC 36712 · Abbreviated New Drug Submission (ANDS)
- IPG-MONTELUKASTDecember 31, 2025 · NOC 36655 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-DONEPEZILDecember 29, 2025 · NOC 36639 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ONDANSETRON INJECTION USP; ONDANSETRON INJECTION USP (PRESERVATIVE FREEDecember 22, 2025 · NOC 36608 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PROPOFOL INJECTIONDecember 19, 2025 · NOC 36585 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-CELECOXIBDecember 12, 2025 · NOC 36803 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-ANASTROZOLEDecember 10, 2025 · NOC 36509 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-CETIRIZINENovember 25, 2025 · NOC 36418 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-RANOLAZINE XROctober 29, 2025 · NOC 36292 · Abbreviated New Drug Submission (ANDS)
- MAR-BILASTINEOctober 28, 2025 · NOC 36317 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-ROSUVASTATINOctober 27, 2025 · NOC 36261 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-GABAPENTINOctober 22, 2025 · NOC 36226 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TREPROSTINIL INJECTIONOctober 10, 2025 · NOC 36153 · Abbreviated New Drug Submission (ANDS)
- TREOSULFAN FOR INJECTIONSeptember 29, 2025 · NOC 36076 · Abbreviated New Drug Submission (ANDS)
- MAR-IBUPROFEN XRSeptember 26, 2025 · NOC 36069 · Abbreviated New Drug Submission (ANDS)
- MAR-ZOPICLONESeptember 16, 2025 · NOC 36010 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-ZOLMITRIPTANSeptember 9, 2025 · NOC 35976 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ZOLEDRONIC ACID FOR INJECTIONSeptember 2, 2025 · NOC 35938 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-DOMPERIDONESeptember 2, 2025 · NOC 35940 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CYCLOPHOSPHAMIDE FOR INJECTION USPAugust 18, 2025 · NOC 35857 · Abbreviated New Drug Submission (ANDS)
- MAR-VENLAFAXINE XRAugust 12, 2025 · NOC 35823 · Abbreviated New Drug Submission (ANDS)
- IPG-QUETIAPINEAugust 7, 2025 · NOC 35891 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-DILTIAZEM TAugust 5, 2025 · NOC 35917 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-MYCOPHENOLIC ACIDJuly 17, 2025 · NOC 35711 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-DONEPEZILJuly 14, 2025 · NOC 35663 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-DOXEPINJuly 10, 2025 · NOC 35656 · Abbreviated New Drug Submission (ANDS)
- IPG-CETIRIZINEMay 26, 2025 · NOC 35429 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-APIXABANMay 26, 2025 · NOC 35439 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BICNUMay 21, 2025 · NOC 35394 · Supplement to a New Drug Submission (SNDS)
- MAR-LEFLUNOMIDEMay 16, 2025 · NOC 35379 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-ROSUVASTATINMay 16, 2025 · NOC 35386 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-ANASTROZOLEMay 16, 2025 · NOC 37052 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-ZOPICLONEMay 2, 2025 · NOC 35292 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-DOMPERIDONEApril 22, 2025 · NOC 35223 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-ZOLMITRIPTANMarch 19, 2025 · NOC 35050 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-KETOROLACFebruary 24, 2025 · NOC 34892 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IBUPROFEN+METHOCARBAMOL CAPLETSFebruary 21, 2025 · NOC 34885 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-PERINDOPRILFebruary 12, 2025 · NOC 34834 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MELPHALAN FOR INJECTIONFebruary 7, 2025 · NOC 34887 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BICNUFebruary 5, 2025 · NOC 34790 · Supplement to a New Drug Submission (SNDS)
- ARSENIC TRIOXIDE FOR INJECTIONJanuary 10, 2025 · NOC 34658 · Abbreviated New Drug Submission (ANDS)
- MAR-PREGABALINJanuary 8, 2025 · NOC 34674 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-GABAPENTINDecember 23, 2024 · NOC 34602 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-QUETIAPINENovember 15, 2024 · NOC 34377 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FUROSEMIDE INJECTION USPNovember 15, 2024 · NOC 34412 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-EZETIMIBENovember 12, 2024 · NOC 34371 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-PREGABALINOctober 25, 2024 · NOC 34311 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-BILASTINEOctober 22, 2024 · NOC 34249 · Abbreviated New Drug Submission (ANDS)
- MAR-FLUOXETINEOctober 21, 2024 · NOC 34235 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-SILDENAFILOctober 21, 2024 · NOC 34238 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-AFATINIBOctober 11, 2024 · NOC 34179 · Abbreviated New Drug Submission (ANDS)
- MAR-ONDANSETRON ODTSeptember 27, 2024 · NOC 34132 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-EZETIMIBESeptember 25, 2024 · NOC 34090 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-LEFLUNOMIDESeptember 19, 2024 · NOC 34054 · Abbreviated New Drug Submission (ANDS)
- MAR-DIENOGESTSeptember 16, 2024 · NOC 34020 · Abbreviated New Drug Submission (ANDS)
- IPG-ROSUVASTATINSeptember 5, 2024 · NOC 33988 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-SILDENAFILAugust 30, 2024 · NOC 33905 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-DILTIAZEM CDAugust 23, 2024 · NOC 33871 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-FLUOXETINEAugust 20, 2024 · NOC 33833 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PROPOFOL INJECTIONAugust 16, 2024 · NOC 33838 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ETOMIDATE INJECTION USPAugust 8, 2024 · NOC 33782 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-METFORMIN XRAugust 6, 2024 · NOC 33764 · Abbreviated New Drug Submission (ANDS)
- MAR-CETIRIZINEAugust 1, 2024 · NOC 33753 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-MODAFINILJuly 18, 2024 · NOC 33660 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-ESCITALOPRAMJuly 10, 2024 · NOC 33601 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-ESZOPICLONEJuly 4, 2024 · NOC 33563 · Abbreviated New Drug Submission (ANDS)
- MAR-PIRFENIDONEJune 28, 2024 · NOC 33541 · Abbreviated New Drug Submission (ANDS)
- MAR-CITALOPRAMJune 3, 2024 · NOC 33379 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-MODAFINILMay 29, 2024 · NOC 33347 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-CETIRIZINEMay 17, 2024 · NOC 33260 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-RIVAROXABANMay 10, 2024 · NOC 33199 · Abbreviated New Drug Submission (ANDS)
- IPG-ESCITALOPRAMMay 9, 2024 · NOC 33192 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-SIMVASTATINApril 18, 2024 · NOC 33086 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IPG-GABAPENTINApril 12, 2024 · NOC 33064 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MAR-ATENOLOLMarch 26, 2024 · NOC 32954 · Supplement to a New Drug Submission (SNDS)
- IPG-CITALOPRAMMarch 22, 2024 · NOC 32955 · Supplement to an Abbreviated New Drug Submission (SANDS)
The latest 100 of 510.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- MAR-AMLODIPINE: affected lots may contain tablet(s) of Midodrine 2.5mg tablets.February 9, 2026 · Drugs · Product safety · Type I
- Two lots of MAR-Amlodipine 5 mg tablets recalled as some bottles may contain the wrong drugFebruary 7, 2026 · Drugs · Product safety
- MAR-Cetirizine 20 mg tablet: Out of specification (Impurities)March 20, 2025 · Drugs · Product quality · Type II
- MAR-Paliperidone Extended Release Tablets: Data IntegrityNovember 16, 2021 · Drugs · Product quality · Type II
- MAR-Cetirizine: ImpurityNovember 9, 2021 · Drugs · Product quality · Type II
- All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concernsSeptember 24, 2020 · Drugs
- MAR-Ketorolac (2019-11-12)November 12, 2019 · Drugs · Product safety · Type II
- MAR-Ketorolac (2019-11-12)November 12, 2019 · Drugs · Product safety · Type III
- BiCNU (carmustine for injection U.S.P.) Lyophilized Powder - Shortage of Canadian labelled BiCNU and replacement with U.S. labelled stock - Notice to HospitalsSeptember 3, 2013 · Drugs · Product safety - Supply
- BiCNU (carmustine for injection, USP) 100 mg/vial - Risk of Myelosuppression, Pulmonary Toxicity, Renal and Hepatic Toxicity as a Result of Overfilled Vials - Notice to HospitalsSeptember 6, 2012 · Drugs
- BiCNU (carmustine for injection) - Type I Recall due to Risk of Infection - Notice to HospitalsJanuary 5, 2010 · Drugs